Gastrointestinal stromal tumor (GIST), the most major mesenchymal neoplasm of the digestive tract, is characterized by KIT or platelet-derived growth factor receptor alpha (PDGFRA) activating mutations, which approximately account for 80% or 10% of GISTs respectively. This evidence concerns the gene KIT and gastrointestinal stromal tumor.